NOW IN YOUR MAILBOX
April must-reads:
Watch your mail for the April issue of Contemporary OB/GYN and the following articles from the magazine you trust to deliver scientific information you can use in ob/gyn practice:
New biomarkers for ovarian cancer: OVA1 and ROMA in diagnosis
New diagnostic assays for ovarian cancer detection are making their way into the clinical armamentarium. Andrew John Li, Co-Director of the Women’s Reproductive Centers of Excellence at Cedars-Sinai Medical Center (Los Angeles), explains why selective use of biomarker testing may lead to better outcomes for women with adnexal masses.
Anal intraepithelial neoplasia and anal cancer: Who should be screened?
Rapidly increasing rates of anal intraepithelial cancer, particularly among women in high-risk groups, are cause for concern. Kevin Ault and his colleagues in the Department of Obstetrics and Gynecology at the Emory University School of Medicine discuss who and how to evaluate for suspicious lesions in the absence of definitive screening guidelines.
Clinician to Clinician: It takes a big man to admit he’s wrong
Steven R. Goldstein, Professor of Obstetrics and Gynecology at the New York University School of Medicine, recounts how his opinion changed about using global endometrial ablation in carefully selected patients.
SMFM Consult: Advanced maternal age and the risk of antepartum stillbirth
Dr. Joanne Stone and the Publications Committee for the Society for Maternal-Fetal Medicine address common questions about the risks of stillbirth in women of advanced maternal age and preventive measures—including timing delivery—that clinicians should consider.
|
